Delivery Order SPE2DB22D3004-SPE2DB23FQC46
Award Date 5/10/23
Potential Completion Date 5/11/23
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,790.09, is for the delivery of the medication Orilissa 150 mg tablets. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,484.68 firm fixed-price delivery order is for Orilissa 150 mg tablets, a prescription medication. The contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distributor Amerisourcebergen Corporation. The $2,745.90 Firm Fixed Price Delivery Order is for the supply of the drug Orilissa 200 mg tablet, with a completion date of June 14, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
- This is a delivery order (SPE2DB22D2007|SPE2DB24FJ0FZ) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,361.44, is for the delivery of the drug Orilissa 150 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. The IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The $2,894.95 contract is for the delivery of the pharmaceutical product Orilissa 150 mg tablets. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- This federal contract award, valued at $1,231.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Orilissa 200 mg tablets for a period ending on April 13, 2022. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical and medical supply distributor. The $3,593.51 firm-fixed-price Delivery Order is for the provision of the prescription drug Orilissa 150 mg tablets. Amerisourcebergen holds two larger Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,406.31 firm fixed-price delivery order is for the supply of the prescription medication Orilissa 200 mg tablets. The contract has an ultimate completion date of August 13, 2024. While no set-aside designation is mentioned, Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,290.82, is for the delivery of Orilissa 150 mg tablets. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...